In 2020, Leapfrog has added new questions for hospitals focused on safe opioid prescribing. These questions will be optional in 2020, and responses will not be scored or publicly reported.
The questions will focus on two areas of opioid prescribing: prescription monitoring via state or regional prescription drug monitoring programs (PDMPs) and adherence to national evidence-based prescribing guidelines for surgical patients.
First, to assess participation in what the Centers for Disease Control and Prevention have identified as a promising practice to improve opioid prescribing and to protect patients, Leapfrog is asking hospitals about their participation in their state or regional prescription drug monitoring program (PDMP) and whether prescribers are required to check the database before writing a new prescription. While Leapfrog originally proposed only including state PDMPs, based on the feedback received, we have updated the questions to include state and regional PDMPs since Missouri does not have a statewide PDMP. These questions are applicable to adult and pediatric hospitals and have also been added to the 2020 Leapfrog ASC Survey.
Second, Leapfrog is asking hospitals to report on their adherence to national evidence-based prescribing guidelines for surgical patients and how they monitor adherence to these guidelines. These measures are not applicable to pediatric hospitals but have been added to the 2020 Leapfrog ASC Survey.